Urinary Tract Infections
📧 Sign up to get email alerts when something new happens for Urinary Tract Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Short Therapy for Febrile UTI in Childhood [Phase 4]
Phase 4 trial update on a short therapy for febrile urinary tract infections in children has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients [Phase 2, Phase 3]
Phase 2/3 trial updates on sitafloxacin and ertapenem for acute urinary tract infections due to E. coli or Klebsiella in post-kidney transpl…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Lactobacillus Probiotic for Prevention of UTI [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial of a Lactobacillus probiotic for prevention of urinary tract infections has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting [Phase 2]
Phase 2 trial update reporting on single-dose aminoglycosides for acute uncomplicated cystitis in the emergency department setting.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Urinary Track Infection Prevention After Urogynecological Surgery [Phase 2]
Phase 2 clinical trial update on prevention of urinary tract infections after urogynecological surgery; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Fecal Microbiota Transplantation (FMT) for MDRO UTI [Phase 1, Phase 2]
Clinical trial evaluating fecal microbiota transplantation for multidrug-resistant organism urinary tract infections has completed phase 1 a…
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection [Phase 4]
A Phase 4 clinical trial evaluated a cytoscopic antibiotic irrigant for reducing postoperative urinary tract infections; results have been p…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Vaginal and Urinary Microbiome Trial [Phase 4]
Phase 4 clinical trial update on vaginal and urinary microbiome related to atrophic vaginitis, menopause, and recurrent urinary tract infect…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Preventing Recurrent Urinary Tract Infections With α-D-mannose [Phase 4]
Phase 4 trial update on preventing recurrent urinary tract infections using α-D-mannose; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections [Phase 3]
Phase 3 trial update on Cefepime-AAI101 for complicated urinary tract infections completed.
-
FDA approval · 2019-12-19FDA Approved: CEFUROXIME AXETIL — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for cefuroxime axetil from Golden State Medical Supply, Inc., recognizing an update to this generic …
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Fixed-dose Amikacin for Elderly UTI [Phase 4]
Phase 4 trial update on fixed-dose amikacin for urinary tract infections in elderly patients.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Clinical trial update for cefotaxime and sulbactam sodium combination in respiratory and urinary tract infections; trial completed with resu…
-
CLINICAL_TRIALS research · 2019-09-11Clinical Trial Update: Women's Improvement of Sexual Health (WISH) Demonstration Project
Clinical trial update for the Women's Improvement of Sexual Health (WISH) Demonstration Project, with completed status and posted results.
-
FDA approval · 2019-08-16FDA Approved: MEROPENEM — Original Application (WG Critical Care, LLC)
FDA approved WG Critical Care, LLC's original ANDA for Meropenem, providing a generic version of the carbapenem antibiotic.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection [Phase 4]
Phase 4 trial update on piperacillin sodium and sulbactam sodium for respiratory and urinary tract infections completed.
-
CLINICAL_TRIALS withdrawal · 2019-06-06Clinical Trial Update: INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI [Phase 4]
A Phase 4 clinical trial investigating intravesical antimicrobial agents versus standard oral antibiotics for acute urinary tract infection …
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Prevention of Post-operative Urinary Retention [Phase 3]
Phase 3 trial update on prevention of post-operative urinary retention, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM) [Phase 2]
Phase 2 clinical trial evaluating oral fosfomycin trometamol for documented male urinary tract infections due to ESBL-producing Enterobacter…
-
CLINICAL_TRIALS safety_alert · 2019-01-29Clinical Trial Update: Fluoroquinolone Associated Disability
Update on safety concerns related to fluoroquinolone antibiotics and the potential risk of disability, affecting patients treated for bronch…
-
FDA approval · 2018-08-10FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Shandong Anxin Pharmaceutical Co., Ltd.)
FDA approved the original application for a generic Piperacillin and Tazobactam combination from Shandong Anxin Pharmaceutical Co., Ltd., ex…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae [Phase 4]
A Phase 4 clinical trial update assesses the efficacy of temocillin for urinary tract infections caused by ESBL-producing and AmpC-hyperprod…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Outcomes of Urinary Tract Infection Management by Pharmacists
A completed clinical trial evaluated outcomes of pharmacist-led management of urinary tract infections.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women [NA]
A completed clinical trial evaluating Lactobacillus reuteri for urinary tract infections in non-pregnant women.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli [Phase 4]
A Phase 4 trial evaluating the non-inferiority of cefoxitin versus imipenem/cilastatin for urinary tract infections caused by ESBL-producing…